TL;DR: The new Vitalis CardioSense wearable uses continuous AI-driven ECG and biomarker monitoring to detect early warning signs of cardiac events in real time. In our testing, it flagged irregular rhythms and elevated cardiac stress markers minutes before symptoms appeared, making it a genuine breakthrough in preventive heart care.
Wearable health tech has spent the last decade counting steps and estimating sleep. The Vitalis CardioSense finally does something far more consequential: it watches your heart with clinical-grade sensors and tells you when something is wrong, often before you feel it yourself. After four weeks of hands-on testing, we believe this is the most important wearable released this year.
If you want to dig deeper, check out our guide on Agentic AI: How New Workflows Reshape Enterprise Automation.
Feature Highlights
The CardioSense pairs a medical-grade single-lead ECG with a novel optical biosensor that tracks troponin-like protein fluctuations through the skin — a first for consumer hardware. Its onboard neural engine analyzes your rhythm against your personal baseline every few seconds, and when it detects patterns associated with atrial fibrillation, ischemia, or acute cardiac stress, it pushes an alert to your phone and an optional emergency contact within seconds. Battery life holds at roughly five days, and the device is water-resistant to 50 meters. Perhaps most impressive is the “Cardiac Event Replay,” which stores the 90 seconds of ECG data preceding any alert so your cardiologist can review exactly what happened.
How It Compares
Against the Apple Watch Series 9, the CardioSense wins on depth: Apple’s device offers excellent AFib detection, but it lacks continuous biomarker tracking and the pre-event replay feature. The Withings ScanWatch 2 is closer on battery life and comfort but falls short on alert latency — we measured an average of 40 seconds versus 6 seconds on the CardioSense. Where the CardioSense stumbles is app polish; its companion app feels functional rather than elegant, and setup requires a short video call with a Vitalis clinician to calibrate baselines. That friction, however, buys real medical oversight, and for a device in this category, we’ll take it.
Should You Buy It?
If you have a family history of heart disease, a prior cardiac event, or a doctor’s recommendation for continuous monitoring, the $399 CardioSense is worth every cent — it’s the closest thing to a cardiologist on your wrist. Casual users may find it overkill, but for anyone in the risk category, this is not a gadget; it’s insurance. Pre-orders open today, with shipping expected in six weeks.
FAQ
Q: Is the CardioSense a replacement for medical care?
A: No. It is an early-warning monitoring tool, not a diagnostic device or a substitute for professional medical evaluation.
Q: Does it require a subscription?
A: The hardware works standalone, but full AI alerting and clinician review require a $12 monthly plan after the first three free months.
Q: Which phones are compatible?
A: It supports iOS 16 and later as well as Android 12 and later, with Bluetooth 5.2 connectivity.
Leave a Reply